Emergent Wealth Advisors LLC Sells 5,428 Shares of Astera Labs, Inc. $ALAB

Emergent Wealth Advisors LLC lowered its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 61.1% during the third quarter, HoldingsChannel.com reports. The firm owned 3,451 shares of the company’s stock after selling 5,428 shares during the period. Emergent Wealth Advisors LLC’s holdings in Astera Labs were worth $676,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in ALAB. Vanguard Group Inc. lifted its stake in Astera Labs by 29.6% in the second quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company’s stock valued at $1,089,491,000 after buying an additional 2,751,747 shares during the period. State Street Corp increased its stake in shares of Astera Labs by 39.3% in the 2nd quarter. State Street Corp now owns 2,143,459 shares of the company’s stock valued at $193,812,000 after acquiring an additional 604,363 shares during the last quarter. 1832 Asset Management L.P. raised its position in shares of Astera Labs by 151.4% in the 2nd quarter. 1832 Asset Management L.P. now owns 1,543,500 shares of the company’s stock valued at $139,563,000 after acquiring an additional 929,600 shares during the period. Massachusetts Financial Services Co. MA boosted its stake in Astera Labs by 46.6% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 1,507,675 shares of the company’s stock worth $295,203,000 after acquiring an additional 479,360 shares during the last quarter. Finally, Geode Capital Management LLC grew its holdings in Astera Labs by 36.2% during the second quarter. Geode Capital Management LLC now owns 1,244,978 shares of the company’s stock valued at $112,562,000 after purchasing an additional 330,841 shares during the period. 60.47% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

ALAB has been the topic of a number of recent analyst reports. TD Cowen reissued a “hold” rating on shares of Astera Labs in a research report on Wednesday, November 5th. JPMorgan Chase & Co. boosted their target price on Astera Labs from $180.00 to $215.00 and gave the company an “overweight” rating in a research note on Wednesday, November 5th. Northland Securities lifted their price objective on Astera Labs from $175.00 to $195.00 and gave the company an “outperform” rating in a report on Tuesday, December 9th. Bank of America started coverage on shares of Astera Labs in a report on Friday, October 3rd. They set a “neutral” rating and a $230.00 target price on the stock. Finally, Needham & Company LLC upped their price target on shares of Astera Labs from $205.00 to $220.00 and gave the company a “buy” rating in a report on Wednesday, November 5th. Fifteen analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $190.63.

Astera Labs Stock Down 3.8%

Shares of ALAB opened at $169.66 on Friday. Astera Labs, Inc. has a twelve month low of $47.13 and a twelve month high of $262.90. The stock has a market capitalization of $28.66 billion, a P/E ratio of 152.85, a P/E/G ratio of 2.41 and a beta of 1.50. The company has a 50 day moving average of $161.80 and a 200-day moving average of $168.80.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.39 by $0.10. The business had revenue of $230.58 million for the quarter, compared to analyst estimates of $206.42 million. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The firm’s revenue for the quarter was up 103.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.23 earnings per share. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, sell-side analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Insider Activity at Astera Labs

In other news, General Counsel Philip Mazzara sold 4,620 shares of the firm’s stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $668,467.80. Following the completion of the transaction, the general counsel owned 147,040 shares in the company, valued at $21,275,217.60. This trade represents a 3.05% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Michael Truett Tate sold 11,430 shares of the company’s stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $1,653,806.70. Following the sale, the chief financial officer owned 192,297 shares in the company, valued at $27,823,452.93. The trade was a 5.61% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 576,936 shares of company stock worth $87,409,540. Corporate insiders own 12.50% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.